Slough, United Kingdom

Hamish Ryder

This inventor holds 1 USPTO granted patent. Top assignee: Xenova Limited. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hamish Ryder. Retrieved from https://idiyas.com/inventor/hamish-ryder-q69m9stp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hamish Ryder

Introduction

Hamish Ryder is a notable inventor based in Slough, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address multi-drug resistance.

Latest Patents

Ryder holds a patent for "Anthranilic acid derivatives as multi-drug resistance modulators." This patent focuses on anthranilic acids of a specific formula, which are designed to enhance the effectiveness of existing drugs against resistant strains of diseases.

Career Highlights

Hamish Ryder is currently employed at Xenova Limited, a company known for its innovative approaches in drug development. His work has been instrumental in advancing research in the pharmaceutical industry.

Collaborations

Ryder has collaborated with notable colleagues, including Philip Anthony Ashworth and Michael Bryan Roe. These partnerships have contributed to the success of his projects and the advancement of their shared goals in research.

Conclusion

Hamish Ryder's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective treatments in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…